Protein Quantification Products & Reviews

RayBio ® G-Series Human Tyrosine Phosphorylation Antibody Array 1 Kit. Detects 507 Human Tyrosine-phosphorylated proteins. Suitable for all liquid sample types but intended for use with cell and tissue lysates.

RayBio ® G-Series Human Protein Serine/Threonine Phosphorylation Array 1 Kit. Detects 507 Human Serine/Threonine-phosphorylated proteins. Suitable for all liquid sample types but intended for use with cell and tissue lysates.

The Queen of high-throughput protein stability characterization. Aunty is the fastest and highest throughput protein stability characterization tool on the planet.

The DPPIV-Glo™ Protease Assay is a homogeneous, luminescent assay that measures dipeptidyl peptidase IV (DPPIV) activity. DPPIV is a serine protease that cleaves N-terminal dipeptides from polypeptides with L-proline or L-alanine at the penultimate position. The DPPIV-Glo™ Assay provides a proluminescent DPPIV substrate, Gly-Pro-aminoluciferin, in a buffer system optimized for DPPIV and luciferase activities. The addition of a…

NanoLuc® Binary Technology (NanoBiT) is a two-subunit system based on NanoLuc® luciferase that can be applied to the intracellular detection of protein:protein interactions (PPIs) in live cells. The NanoBiT® system is composed of two small subunits, Large BiT (LgBiT; 18kDa) and Small BiT (SmBiT; 11 amino acid peptide), that are expressed as fusions to target proteins of interest. The LgBiT and SmBiT subunits have been independ…

The Succinate-Glo™ JmjC Demethylase/Hydroxylase Assay is a bioluminescent assay for detecting the activity of JumonjiC (JmjC) histone demethylases and many Fe(II)/α-ketoglutarate-dependent dioxygenases that use α-ketoglutarate as substrate and release succinate as a product.

The NanoBRET™ Target Engagement (TE) Intracellular BET BRD Assay measures compound binding at select BET bromodomain target proteins within intact cells. This target engagement assay is based on the NanoBRET™ System, an energy transfer technique designed to measure molecular proximity in living cells

BRET-Based Assays to Detect Protein:Protein Interactions in Live Cells

The Affinity ITC provides unmatched sample reproducibility with the highest sensitivity, innovative technology, and industry-proven reliability.

The Nano ITC is designed to provide maximum sensitivity and flexibility for the study of biomolecular binding.

Recombinant monoclonal antibody to ENG. It is a human monoclonal antibody that can be potentially used in the treatment of Hepatocellular Carcinoma, Gestational Trophoblastic Neoplasia, Choriocarcinoma, Placental Site Trophoblastic Tumor, Epithelioid Trophoblastic Tumor, Adult Solid Tumor, Advanced Soft Tissue Sarcoma, Metastatic Breast Cancer, Solid Tumors, Lung Cancer...

This product is a recombinant Human antibody that recognizes CRCP. The antibody was purified by affinity chromatography.

This product is a Human antibody that recognizes Human HLA-A*11:01.

This product is a Mouse antibody that recognizes Human Fc P329G LALA.

Recombinant monoclonal antibody to 4-1BB. This anti-4-1BB antibody is a fully human IgG4 monoclonal antibody targeting the CD137 receptor. It specifically binds to and activates CD137-expressing immune cells, stimulating an immune response, in particular a cytotoxic T cell response, against tumor cells.

This product is a human IgG1, κ antibody that can recognize human NECTIN4.

Recombinant human monoclonal antibody expressed in CHO binds to the human interferon α/β receptor. It is a monoclonal antibody designed for the treatment of systemic lupus erythematosus.

This recombinant monoclonal antibody is a humanized monoclonal antibody that specifically recognizes human IL-23A and has potent affinity against IL-23A. It can also be potentially used in the research of Crohn's disease, psoriasis, psoriatic arthritis, and asthma.

Recombinant Human Antibody (M22) is capable of binding to TSHR, expressed in HEK 293 cells. Expressed as the combination of a heavy chain (HC) containing VH from anti-TSHR mAb and the CH1-3 region of human IgG and a light chain (LC) encoding VL from anti-TSHR mAb and CL of human kappa light chain. Exists as a disulfide-linked dimer of the HC and LC heterodimer under non-reducing conditions.

Recombinant Human Antibody (FI6V3) is capable of binding to IAV HA, expressed in HEK 293 cells. Expressed as the combination of a heavy chain (HC) containing VH from anti-IAV HA mAb and the CH1-3 region of human IgG1 and a light chain (LC) encoding VL from anti-IAV HA mAb and CL of human kappa light chain. Exists as a disulfide-linked dimer of the HC and LC heterodimer under non-reducing conditions.

Recombinant Human Antibody (K1-70) is capable of binding to the TSH receptor (TSHR), expressed in HEK 293 cells. Expressed as the combination of a heavy chain (HC) containing VH from anti-TSH receptor (TSHR) mAb and the CH1-3 region of human IgG1 and a light chain (LC) encoding VL from anti-TSH receptor (TSHR) proteins mAb and CL of human kappa light chain.

This product is a recombinant Human antibody that recognizes PDCD1. The antibody was expressed in mammalian cells with chemically defined culture media and was purified by affinity chromatography.

Recombinant Human Antibody (D25) is capable of binding to RSV, expressed in HEK 293 cells. Expressed as the combination of a heavy chain (HC) containing VH from anti-RSV mAb and CH1-3 region of human IgG1 and a light chain (LC) encoding VL from anti-RSV mAb and CL of human kappa light chain. Exists as a disulfide linked dimer of the HC and LC hetero-dimer under non-reducing condition.

The antibody specifically targets the CD3 epsilon chain present on T lymphocytes. It binds to the CD3 molecule on the surface of T cells. By engaging with CD3, the mAb alters the immune response, offering potential in decelerating the progression of type 1 diabetes.

This product is a human monoclonal IgG1 kappan antibody targeting the Gnl domain of glycoprotein N (Gn) of severe fever with thrombocytopenia syndrome virus (SFTSV). This antibody shows the ability to neutralize SFTSV broadly, using the antibody neutralization of the SFTSV, which makes the antibody a specific drug and so clinically useful in preventing SFTSV through the treatment studies of diseases caused by infection.